ASND
Ascendis Pharma A/S
Stock
$227.87+0.56 (+0.25%)Close Oct 2, 2026
- Capital expenditures, 2023
- €2.4M
- YoY, 2023
- −83.1%
- 5-year CAGR
- −1.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2023 | €2.4M | −83.1% |
| 2022 | €14M | −38.9% |
| 2021 | €24M | +19.4% |
| 2020 | €20M | +285.0% |
| 2019 | €5.2M | +94.8% |
| 2018 | €2.6M | +181.4% |
| 2017 | €941K | +40.0% |
| 2016 | €672K | −35.3% |
| 2015 | €1.0M | — |